SNORD3A and breast cancer: To determine whether SNORD3A enhancement of the sensitivity to 5-FU in breast cancer cells is dependent on UMPS, we stably knocked down UMPS in breast cancer cells with ectopic SNORD3A overexpression (Fig. 2e).